Cite

HARVARD Citation

    Brunner, A. et al. (2020). Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial. Lancet. 7 (2), pp. e122-e133. [Online]. 
  
Back to record